213 related articles for article (PubMed ID: 27429187)
1. Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis.
Grant RM; Sevelius JM; Guanira JV; Aguilar JV; Chariyalertsak S; Deutsch MB
J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 3(Suppl 3):S226-9. PubMed ID: 27429187
[TBL] [Abstract][Full Text] [Related]
2. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
Deutsch MB; Glidden DV; Sevelius J; Keatley J; McMahan V; Guanira J; Kallas EG; Chariyalertsak S; Grant RM;
Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965
[TBL] [Abstract][Full Text] [Related]
3. The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices.
Sevelius JM; Deutsch MB; Grant R
J Int AIDS Soc; 2016; 19(7(Suppl 6)):21105. PubMed ID: 27760683
[TBL] [Abstract][Full Text] [Related]
4. Pre-Exposure Prophylaxis in Trans Populations: Providing Gender-Affirming Prevention for Trans People at High Risk of Acquiring HIV.
Deutsch MB
LGBT Health; 2018 Oct; 5(7):387-390. PubMed ID: 30272493
[TBL] [Abstract][Full Text] [Related]
5. HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender and gender diverse adults in the United States: a conjoint analysis.
Watson DL; Listerud L; Drab RA; Lin WY; Momplaisir FM; Bauermeister JA
J Int AIDS Soc; 2024 Feb; 27(2):e26211. PubMed ID: 38332521
[TBL] [Abstract][Full Text] [Related]
6. Acceptability of HIV Pre-Exposure Prophylaxis Among Transgender Women in India: A Qualitative Investigation.
Chakrapani V; Shunmugam M; Rawat S; Baruah D; Nelson R; Newman PA
AIDS Patient Care STDS; 2020 Feb; 34(2):92-98. PubMed ID: 31951490
[TBL] [Abstract][Full Text] [Related]
7. 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women.
Sevelius JM; Keatley J; Calma N; Arnold E
Glob Public Health; 2016; 11(7-8):1060-75. PubMed ID: 26963756
[TBL] [Abstract][Full Text] [Related]
8. Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial.
Sagaon-Teyssier L; Suzan-Monti M; Demoulin B; Capitant C; Lorente N; Préau M; Mora M; Rojas Castro D; Chidiac C; Chas J; Meyer L; Molina JM; Spire B;
AIDS Care; 2016; 28 Suppl 1(sup1):48-55. PubMed ID: 26883400
[TBL] [Abstract][Full Text] [Related]
9. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.
Grant RM; Anderson PL; McMahan V; Liu A; Amico KR; Mehrotra M; Hosek S; Mosquera C; Casapia M; Montoya O; Buchbinder S; Veloso VG; Mayer K; Chariyalertsak S; Bekker LG; Kallas EG; Schechter M; Guanira J; Bushman L; Burns DN; Rooney JF; Glidden DV;
Lancet Infect Dis; 2014 Sep; 14(9):820-9. PubMed ID: 25065857
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L;
Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274
[TBL] [Abstract][Full Text] [Related]
11. Uptake, Retention, and Adherence to Pre-exposure Prophylaxis (PrEP) in TRIUMPH: A Peer-Led PrEP Demonstration Project for Transgender Communities in Oakland and Sacramento, California.
Sevelius JM; Glidden DV; Deutsch M; Welborn L; Contreras A; Salinas A; Venegas L; Grant RM
J Acquir Immune Defic Syndr; 2021 Dec; 88(S1):S27-S38. PubMed ID: 34757990
[TBL] [Abstract][Full Text] [Related]
12. Awareness and Willingness to use HIV Pre-exposure Prophylaxis (PrEP) Among Trans Women in China: A Community-Based Survey.
Yan L; Yan Z; Wilson E; Arayasirikul S; Lin J; Yan H; McFarland W
AIDS Behav; 2021 Mar; 25(3):866-874. PubMed ID: 32989576
[TBL] [Abstract][Full Text] [Related]
13. HIV pre-exposure prophylaxis (PrEP) awareness and acceptability among trans women: a review.
Pacífico de Carvalho N; Mendicino CCP; Cândido RCF; Alecrim DJD; Menezes de Pádua CA
AIDS Care; 2019 Oct; 31(10):1234-1240. PubMed ID: 31043069
[TBL] [Abstract][Full Text] [Related]
14. The Role of Social Relationships in PrEP Uptake and Use Among Transgender Women and Men Who Have Sex with Men.
Mehrotra ML; Rivet Amico K; McMahan V; Glidden DV; Defechereux P; Guanira JV; Grant RM
AIDS Behav; 2018 Nov; 22(11):3673-3680. PubMed ID: 29754268
[TBL] [Abstract][Full Text] [Related]
15. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
[TBL] [Abstract][Full Text] [Related]
16. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.
Antoni G; Tremblay C; Delaugerre C; Charreau I; Cua E; Rojas Castro D; Raffi F; Chas J; Huleux T; Spire B; Capitant C; Cotte L; Meyer L; Molina JM;
Lancet HIV; 2020 Feb; 7(2):e113-e120. PubMed ID: 31784343
[TBL] [Abstract][Full Text] [Related]
17. "Some of us, we don't know where we're going to be tomorrow." Contextual factors affecting PrEP use and adherence among a diverse sample of transgender women in San Francisco.
Cahill SR; Keatley J; Wade Taylor S; Sevelius J; Elsesser SA; Geffen SR; Wang T; Mayer KH
AIDS Care; 2020 May; 32(5):585-593. PubMed ID: 31482726
[TBL] [Abstract][Full Text] [Related]
18. Implementation of a Test, Treat, and Prevent HIV program among men who have sex with men and transgender women in Thailand, 2015-2016.
Ongwandee S; Lertpiriyasuwat C; Khawcharoenporn T; Chetchotisak P; Thiansukhon E; Leerattanapetch N; Leungwaranan B; Manopaiboon C; Phoorisri T; Visavakum P; Jetsawang B; Poolsawat M; Nookhai S; Vasanti-Uppapokakorn M; Karuchit S; Kittinunvorakoon C; Mock P; Prybylski D; Sukkul AC; Roels T; Martin M
PLoS One; 2018; 13(7):e0201171. PubMed ID: 30044867
[TBL] [Abstract][Full Text] [Related]
19. Perceived HIV Acquisition Risk and Low Uptake of PrEP Among a Cohort of Transgender Women With PrEP Indication in the Eastern and Southern United States.
Malone J; Reisner SL; Cooney EE; Poteat T; Cannon CM; Schneider JS; Radix A; Mayer KH; Haw JS; Althoff KN; Wawrzyniak AJ; Beyrer C; Wirtz AL;
J Acquir Immune Defic Syndr; 2021 Sep; 88(1):10-18. PubMed ID: 34397742
[TBL] [Abstract][Full Text] [Related]
20. Mapping Community-Engaged Implementation Strategies with Transgender Scientists, Stakeholders, and Trans-Led Community Organizations.
Restar A; Minalga BJ; Quilantang MI; Adamson T; Dusic E; van der Merwe LA; Millet G; Rosadiño D; Laguing T; Lett E; Everhart A; Phillips G; Janamnuaysook R; Seekaew P; Baker K; Ashley F; Wickersham J; Wallace SE; Operario D; Gamarel KE
Curr HIV/AIDS Rep; 2023 Jun; 20(3):160-169. PubMed ID: 37012537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
